Status:
COMPLETED
Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2
Lead Sponsor:
Danish Headache Center
Conditions:
Headache
Migraine
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to ...
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- Primary Headache, headache on the day of the investigation, hypertension, hypotension, pregnant/nursing, daily intake of medication (except oral contraceptives), Cardiovascular or CNS disease, drug/alcohol abuse, psychiatric disease
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00374530
Start Date
August 1 2006
Last Update
August 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Headache Center
Glostrup Municipality, Glostrup, Denmark, DK-2600